spacer
spacer

PDBsum entry 3jy9

Go to PDB code: 
protein ligands metals links
Transferase PDB id
3jy9

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
284 a.a. *
Ligands
JZH
Metals
_NA
Waters ×176
* Residue conservation analysis
PDB id:
3jy9
Name: Transferase
Title: Janus kinase 2 inhibitors
Structure: Tyrosine-protein kinase jak2. Chain: a. Fragment: unp residue 842-1130, protein kinase 2 domain. Synonym: janus kinase 2, jak-2. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: jak2. Expressed in: baculovirus. Expression_system_taxid: 10469.
Resolution:
2.10Å     R-factor:   0.201     R-free:   0.271
Authors: H.J.Zuccola,M.W.Ledeboer,A.C.Pierce
Key ref: T.Wang et al. (2009). Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole. J Med Chem, 52, 7938-7941. PubMed id: 20014869
Date:
21-Sep-09     Release date:   01-Dec-09    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
O60674  (JAK2_HUMAN) -  Tyrosine-protein kinase JAK2 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1132 a.a.
284 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.7.10.2  - non-specific protein-tyrosine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
L-tyrosyl-[protein]
+ ATP
= O-phospho-L-tyrosyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
J Med Chem 52:7938-7941 (2009)
PubMed id: 20014869  
 
 
Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole.
T.Wang, J.P.Duffy, J.Wang, S.Halas, F.G.Salituro, A.C.Pierce, H.J.Zuccola, J.R.Black, J.K.Hogan, S.Jepson, D.Shlyakter, S.Mahajan, Y.Gu, T.Hoock, M.Wood, B.F.Furey, J.D.Frantz, L.M.Dauffenbach, U.A.Germann, B.Fan, M.Namchuk, Y.L.Bennani, M.W.Ledeboer.
 
  ABSTRACT  
 
The synthesis and characterization of a novel polycyclic azaindole based derivative is disclosed, and its binding to JAK2 is described. The compound is further evaluated for its ability to block the EPO/JAK2 signaling cascade in vitro and in vivo.
 

 

spacer

spacer